Roberta Brusa
Overview
Explore the profile of Roberta Brusa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pezzoni L, Brusa R, Difonzo T, Magri F, Velardo D, Corti S, et al.
Neurol Sci
. 2023 Nov;
45(4):1691-1698.
PMID: 37968431
Background: Distrophinopathies are a heterogeneous group of neuromuscular disorders due to mutations in the DMD gene. Different isoforms of dystrophin are also expressed in the cerebral cortex and Purkinje cells....
2.
Fortunato F, Bianchi F, Ricci G, Torri F, Gualandi F, Neri M, et al.
Orphanet J Rare Dis
. 2023 Jul;
18(1):196.
PMID: 37480080
Background: The development of e-health technologies for teleconsultation and exchange of knowledge is one of the core purposes of European Reference Networks (ERNs), including the ERN EURO-NMD for rare neuromuscular...
3.
Gagliardi D, Rizzuti M, Brusa R, Ripolone M, Zanotti S, Minuti E, et al.
J Cell Mol Med
. 2022 Jul;
26(17):4678-4685.
PMID: 35880500
Becker muscular dystrophy (BMD) is an X-linked neuromuscular disorder due to mutation in the DMD gene, encoding dystrophin. Despite a wide clinical variability, BMD is characterized by progressive muscle degeneration...
4.
Gagliardi D, Faravelli I, Podesta M, Brusa R, Mauri E, Saccomanno D, et al.
Front Neurol
. 2021 Sep;
12:729252.
PMID: 34557155
Guillain-Barré syndrome (GBS) is an inflammatory polyradiculopathy with potentially severe complications. Clinical tools for risk stratification have been developed, but no definitive prognostic biomarker has been reported. Hyponatremia is frequent...
5.
Gagliardi D, Costamagna G, Abati E, Mauri E, Brusa R, Scudeller L, et al.
Muscle Nerve
. 2021 Jul;
64(4):474-482.
PMID: 34296433
Introduction: /AIMS: Patients with neuromuscular disorders (NMDs), including many elderly, immunosuppressed, and disabled individuals, may have been particularly affected during the coronavirus disease 2019 (COVID-19) pandemic in Lombardy, a COVID-19...
6.
Mauri E, Piga D, Govoni A, Brusa R, Pagliarani S, Ripolone M, et al.
Front Neurol
. 2021 Jul;
12:664618.
PMID: 34262519
Ryanodine receptor type 1-related congenital myopathies are the most represented subgroup among congenital myopathies (CMs), typically presenting a central core or multiminicore muscle histopathology and high clinical heterogeneity. We evaluated...
7.
Pietroboni A, Lanfranconi S, Novella A, Carandini T, Arighi A, Abati E, et al.
Intern Emerg Med
. 2021 Feb;
16(5):1247-1252.
PMID: 33565035
Since the end of February 2020, Italy has suffered one of the most severe outbreaks of coronavirus disease 2019 (COVID-19). However, what happened just before the Italian index case has...
8.
Costamagna G, Meneri M, Abati E, Brusa R, Velardo D, Gagliardi D, et al.
Medicine (Baltimore)
. 2020 Oct;
99(43):e22900.
PMID: 33120840
Rationale: Spinal cord infarction (SCI) accounts for only 1% to 2% of all ischemic strokes and 5% to 8% of acute myelopathies. Magnetic resonance imaging (MRI) holds a role in...
9.
Brusa R, Mauri E, DellArti L, Magri F, Ronchi D, Minorini V, et al.
Neurol Genet
. 2020 Oct;
6(5):e511.
PMID: 33062892
No abstract available.
10.
Magri F, Brusa R, Bello L, Peverelli L, Del Bo R, Govoni A, et al.
Acta Myol
. 2020 Sep;
39(2):67-82.
PMID: 32904964
Mutations in gene, encoding merosin, are generally responsible of a severe congenital-onset muscular dystrophy (CMD type 1A) characterized by severe weakness, merosin absence at muscle analysis and white matter alterations...